The evolution of microarrayed compound screening

Drug Discov Today. 2004 Apr 15;9(8):358-65. doi: 10.1016/S1359-6446(04)03037-5.

Abstract

This review describes recent developments in the evolutionary process of microarrayed compound screening (microARCS to become a robust and efficient ultra-high-throughput screening technology. Improvements in compound spotting (including new quality-control methods), gel casting and imaging, together with software capable of automatic analysis and deconvolution of images, have helped to streamline the screening process. A variety of screening projects using cell-based and non-cell-based approaches have been successfully concluded using microARCS. Comparison of hits derived from standard microtitre-plate-based screening and from microARCS reveals excellent overlap. Furthermore, there seems to be no bias towards finding compounds within a particular range of logP values, even though compounds are solubilized from a dry state during the course of the assay.

Publication types

  • Review

MeSH terms

  • Biological Assay / methods
  • Chemistry, Pharmaceutical / methods*
  • Drug Evaluation, Preclinical / methods*
  • Gels
  • Miniaturization / instrumentation
  • Miniaturization / methods
  • Pharmaceutical Preparations / chemistry*
  • Software
  • Structure-Activity Relationship

Substances

  • Gels
  • Pharmaceutical Preparations